
Cyclophosphamide Injection
| Product/Composition:- | Cyclophosphamide Injection |
|---|---|
| Strength:- | 200mg, 500mg, 1gm |
| Form:- | Injection |
| Production Capacity | 1 Million Injection/Month |
| Therapeutic use:- | Anti Cancer |
| Package Insert/Leaflet: | Available upon request |
Cyclophosphamide Injection
-
Type: Chemotherapy medication
-
Drug Class: Alkylating agent (nitrogen mustard derivative)
-
Form: Sterile powder for reconstitution or solution, given intravenously (IV)
How It Works
-
Cyclophosphamide is a prodrug (inactive form) that becomes active in the liver.
-
The active form attaches alkyl groups to DNA, causing cross-linking and preventing DNA replication.
-
This stops rapidly dividing cancer cells (and some normal cells) from growing, leading to cell death.
Common Uses
Cyclophosphamide injection is widely used in cancer treatment and some immune disorders:
Cancer Treatment
-
Breast cancer
-
Lymphomas (Hodgkin and non-Hodgkin)
-
Leukemias
-
Multiple myeloma
-
Ovarian cancer
-
Small cell lung cancer
-
Sarcomas
Non-Cancer Uses (Immunosuppressive Therapy)
-
Severe autoimmune diseases (e.g., lupus nephritis, vasculitis)
-
Bone marrow transplant conditioning
Advantages
-
Very effective and versatile drug used in many chemotherapy regimens
-
Can be given alone or combined with other anticancer medicines
-
Also helpful for immune system–related conditions where strong immunosuppression is needed
Possible Side Effects
Cyclophosphamide affects both cancer cells and healthy rapidly dividing cells, so side effects may occur:
Common
-
Nausea, vomiting
-
Hair loss (alopecia)
-
Low blood cell counts (increased infection risk, anemia, bleeding tendency)
-
Loss of appetite, fatigue
Serious/Specific
-
Hemorrhagic cystitis (bladder irritation and bleeding — prevented with hydration and mesna)
-
Infertility (may affect ovaries or testes)
-
Heart toxicity (at very high doses)
-
Secondary cancers (rare, with long-term use)
Precautions
-
Patients must stay well-hydrated to prevent bladder damage
-
Blood counts need regular monitoring
-
Use with caution in patients with liver or kidney impairment
-
Avoid live vaccines during treatment due to immunosuppression
-
Should only be given under specialist supervision